Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02867657
Other study ID # H-15010925
Secondary ID
Status Recruiting
Phase N/A
First received August 10, 2016
Last updated February 7, 2018
Start date June 2016
Est. completion date November 2018

Study information

Verified date February 2018
Source VIA University College
Contact Jesper Dahlgaard, PhD
Phone +45 8755 2992
Email jesd@via.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine whether a five day mindfulness retreat in nature can increase measures of attention and self-compassion, and reduce stress among bachelor students at Danish Universities and University Colleges. Secondary whether the expression of inflammatory markers can be reduced .

It is the hypothesis that perceived stress is reduced and the expression of genetic markers of inflammation is reduced after a five day mindfulness retreat.


Recruitment information / eligibility

Status Recruiting
Enrollment 72
Est. completion date November 2018
Est. primary completion date March 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Bachelor student at a Danish University or University College

- A score of 16 or above on the Perceived Stress Scale (PSS)

Exclusion Criteria:

- Smoking

- Psychiatric diagnosis (depression, anxiety, adjustment disorder, PTSD, personality disorder, psychosis).

- Untreated ADHD, autism, abuse and risk of suicide

Study Design


Intervention

Behavioral:
Mindfulness
Five days MBSR curriculum with meditation and yoga

Locations

Country Name City State
Denmark VIA University College Aarhus
Denmark Nacadia, University of Copenhagen Hoersholm

Sponsors (3)

Lead Sponsor Collaborator
VIA University College University of Aarhus, University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Perceived Stress Scale PSS At the end of five days retreat
Primary Self-compassion S-C-S Neff2 At the end of five days retreat
Secondary Five Facet Mindfulness Questionnaire At the end of five days retreat
Secondary Breath Counting Behavioral measurement of attention At the end of five days retreat
Secondary NF-kB gene expression At the end of five days retreat
Secondary IL-1 gene expression At the end of five days retreat
Secondary IL-6 gene expression At the end of five days retreat
Secondary cRP expression c reactive protein At the end of five days retreat
Secondary Heart Rate Variability HRV At the end of five days retreat
Secondary Blood pressure At the end of five days retreat
Secondary Connectedness to Nature Scale At the end of five days retreat
Secondary GR gene expression At the end of five days retreat
Secondary RIPK2 gene expression At the end of five days retreat
Secondary TNF-a gene expression At the end of five days retreat
Secondary CCL5 gene expression At the end of five days retreat
Secondary IL-8 gene expression At the end of five days retreat
Secondary TERT gene expression At the end of five days retreat
Secondary TERC gene expression At the end of five days retreat
Secondary IL-1ß protein expression At the end of five days retreat
Secondary IL-2 protein expression At the end of five days retreat
Secondary IL-4 protein expression At the end of five days retreat
Secondary IL-6 protein expression At the end of five days retreat
Secondary IL-8 protein expression At the end of five days retreat
Secondary IL-10 protein expression At the end of five days retreat
Secondary IL-12p70 protein expression At the end of five days retreat
Secondary IL-13 protein expression At the end of five days retreat
Secondary TNF-a protein expression At the end of five days retreat
Secondary IFN-? protein expression At the end of five days retreat
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT06422494 - The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II N/A